Literature DB >> 12007036

[Outcomes of cardiac rehabilitation treatment and cost-effectiveness relations--A comparison between inpatient and outpatient rehabilitation programmes].

A Vom Orde1, T Schott, O Iseringhausen.   

Abstract

Regarding the dominance of inpatient medical rehabilitation programmes efforts have emerged over the last few years to strengthen outpatient medical rehabilitation programmes in Germany. The goal of cardiac rehabilitation is the recovery of physical, psychic and social wellbeing in people with a severe heart condition. For this contribution the central outcomes of cardiac rehabilitation were compared between different rehabilitation programmes (inpatient and outpatient) and cost-effectiveness analyses were made. These results were obtained within the scope of an evaluation study commissioned by the statutory health and pension insurance agency. In summary, the different rehabilitation programmes can be regarded as comparable concerning effectiveness and costs following rehabilitation.

Entities:  

Mesh:

Year:  2002        PMID: 12007036     DOI: 10.1055/s-2002-28446

Source DB:  PubMed          Journal:  Rehabilitation (Stuttg)        ISSN: 0034-3536            Impact factor:   1.113


  3 in total

1.  Intervention study shows outpatient cardiac rehabilitation to be economically at least as attractive as inpatient rehabilitation.

Authors:  Bernd Schweikert; Harry Hahmann; Jürgen M Steinacker; Armin Imhof; Rainer Muche; Wolfgang Koenig; Yufei Liu; Reiner Leidl
Journal:  Clin Res Cardiol       Date:  2009-10-11       Impact factor: 5.460

Review 2.  [Catheter ablation for atrial fibrillation: clinically established or still an experimental method?].

Authors:  Stephan Willems; Boris Hoffmann; Daniel Steven; Imke Drewitz; Helge Servatius; Kai Müllerleile; Thomas Meinertz; Thomas Rostock
Journal:  Herz       Date:  2008-09       Impact factor: 1.443

3.  Spinal deformities rehabilitation - state of the art review.

Authors:  Hans-Rudolf Weiss
Journal:  Scoliosis       Date:  2010-12-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.